Article
Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype.
Experimental hematology - 1 Jan 2016
Moses Blake S, Slone William L, Thomas Patrick, Evans Rebecca, Piktel Debbie, Angel Peggi M, Walsh Callee M, Cantrell Pamela S, Rellick Stephanie L, Martin Karen H, Simpkins James W, Gibson Laura F
Abstract excerpt
Acute lymphoblastic leukemia (ALL) treatment regimens have dramatically improved the survival of ALL patients. However, chemoresistant minimal residual disease that persists following cessation of therapy contributes to aggressive relapse. The bone marrow microenvironment (BMM) is an established "site of sanctuary" for ALL, as well as myeloid-lineage hematopoietic disease, with signals in this unique anatomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
